The percentage of CD4+CD25+FoxP3+ Tregs among the total tumor-infiltrated CD4+ cells is 44.45 ± 9.03 in control group as compared to 6.47 ± 1.18 in NIR treated group (P < 0.005; Student’s t-test). The gene discussed is CD4; the disease is neoplasm.